Board suspends licenses of four pharmaceutical practitioners for professional misconduct
The Pharmacy and Poisons Board (PPB) Enquiries and Disciplinary Committee (EDC) has suspended the licenses of four pharmaceutical practitioners for professional misconduct.
In a decision led by the Committee’s Chairperson, Dr. Richard Muthoka, two pharmaceutical technologists had their licenses suspended for two years.
Their offences included allowing unlicensed individuals to access their professional credentials and manage their licensed premises, thereby jeopardizing public health.
PPB Chief Executive Officer Dr. Fred Siyoi in a statement to newsrooms said that another pharmaceutical technologist received a three-month suspension for failing to ensure the proper closure of a former premises, which allowed an unqualified person to continue overseeing operations, posing a risk to public safety.
“In a separate ruling, the Committee also suspended the license of a pharmaceutical technologist for a period of three years after they were found impersonating a student during the Board’s May 2024 examination series,” said Dr. Siyoi.
“After a thorough review of the facts and your written confessions, the Board concludes that your actions represent a serious breach of trust and integrity, essential qualities for anyone in the pharmaceutical field,” read part of the Committee’s decision.
Dr. Siyoi reaffirmed the Board’s commitment to regulating the pharmacy profession to protect public health.
